Skip to content

Validity of Electronic Diary for Monitoring Varicose Veins Symptoms

Performance of Daily Electronic Diary to Capture Venous Symptoms Before and After Intervention for Great Saphenous Vein Incompetence

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01200199
Enrollment
45
Registered
2010-09-13
Start date
2010-11-30
Completion date
2011-08-31
Last updated
2021-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicose Veins

Brief summary

The purpose of this study is to contribute to the validation of an electronic daily diary to assess symptoms in patients with varicose veins.

Interventions

None listed

Sponsors

Boston Scientific Corporation
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Sign informed consent and complete study assessments in written English * Male or female age 18 to 75 * Patients having Saphenofemoral Junction (SFJ) incompetence and scheduled to receive foam sclerotherapy treatment for varicose veins in one leg * Screening Symptom score of 7 points or more as measured by Question 1 on the modified VEINES-QOL/Sym questionnaire

Exclusion criteria

* Unable to comply with completing a daily diary for a total of 24 days * Participation in any other investigational pharmaceutical product, or device study within the 3 months prior to Visit 1 * Current venous leg ulcer in either leg

Design outcomes

Primary

MeasureTime frame
To assess the feasibility, variability, validity and sensitivity of patient's varicose vein symptoms using a disease-specific symptom questionnaire, administered as a daily electronic diary in patients undergoing treatment for varicose veins8 weeks

Secondary

MeasureTime frame
To establish the treatment effect size of foam sclerotherapy treatment8 weeks

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026